Wright Medical Group N.V. (NASDAQ:WMGI) – Research analysts at William Blair increased their FY2017 earnings estimates for shares of Wright Medical Group N.V. in a report released on Thursday. William Blair analyst K. Krum now forecasts that the medical device company will post earnings per share of ($0.27) for the year, up from their prior estimate of ($0.30). William Blair also issued estimates for Wright Medical Group N.V.’s Q4 2017 earnings at $0.04 EPS.

Wright Medical Group N.V. (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, August 2nd. The medical device company reported ($0.07) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.02. Wright Medical Group N.V. had a negative return on equity of 6.08% and a negative net margin of 36.04%. The company had revenue of $179.69 million for the quarter, compared to analyst estimates of $178.17 million. During the same period in the previous year, the company posted ($0.11) earnings per share. The firm’s revenue was up 5.3% on a year-over-year basis.

ILLEGAL ACTIVITY WARNING: “Wright Medical Group N.V. to Post FY2017 Earnings of ($0.27) Per Share, William Blair Forecasts (NASDAQ:WMGI)” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/07/wright-medical-group-n-v-to-post-fy2017-earnings-of-0-27-per-share-william-blair-forecasts-nasdaqwmgi.html.

Several other research analysts have also recently issued reports on the company. BidaskClub cut Wright Medical Group N.V. from a “hold” rating to a “sell” rating in a research note on Saturday. Jefferies Group LLC reissued a “buy” rating and issued a $33.00 price objective on shares of Wright Medical Group N.V. in a research note on Friday. Piper Jaffray Companies reissued a “buy” rating and issued a $34.00 price objective on shares of Wright Medical Group N.V. in a research note on Thursday. Oppenheimer Holdings, Inc. set a $30.00 price objective on Wright Medical Group N.V. and gave the stock a “hold” rating in a research note on Thursday. Finally, Cantor Fitzgerald assumed coverage on Wright Medical Group N.V. in a research note on Thursday, June 29th. They issued an “overweight” rating and a $33.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $31.67.

Shares of Wright Medical Group N.V. (NASDAQ:WMGI) opened at 27.45 on Monday. The company’s 50 day moving average price is $27.03 and its 200 day moving average price is $27.85. The company’s market capitalization is $2.87 billion. Wright Medical Group N.V. has a 52-week low of $20.50 and a 52-week high of $31.53.

In other Wright Medical Group N.V. news, SVP Jonathan Wesley Porter sold 2,490 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $27.09, for a total transaction of $67,454.10. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Lance A. Berry sold 6,685 shares of the stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $27.14, for a total value of $181,430.90. The disclosure for this sale can be found here. Insiders have sold a total of 40,655 shares of company stock worth $1,116,708 in the last ninety days. Insiders own 9.30% of the company’s stock.

Hedge funds have recently bought and sold shares of the company. Norges Bank acquired a new stake in Wright Medical Group N.V. during the fourth quarter worth $4,711,000. Macquarie Group Ltd. boosted its stake in Wright Medical Group N.V. by 13.3% in the fourth quarter. Macquarie Group Ltd. now owns 797,339 shares of the medical device company’s stock worth $18,323,000 after buying an additional 93,771 shares during the last quarter. Nationwide Fund Advisors boosted its stake in Wright Medical Group N.V. by 4.8% in the first quarter. Nationwide Fund Advisors now owns 314,403 shares of the medical device company’s stock worth $9,784,000 after buying an additional 14,310 shares during the last quarter. Independent Portfolio Consultants Inc. acquired a new stake in Wright Medical Group N.V. during the first quarter worth $276,000. Finally, Granite Investment Partners LLC boosted its stake in Wright Medical Group N.V. by 10.2% in the first quarter. Granite Investment Partners LLC now owns 431,412 shares of the medical device company’s stock worth $13,425,000 after buying an additional 39,847 shares during the last quarter.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Earnings History and Estimates for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.